1. Home
  2. PHVS vs CIFR Comparison

PHVS vs CIFR Comparison

Compare PHVS & CIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • CIFR
  • Stock Information
  • Founded
  • PHVS 2015
  • CIFR 2021
  • Country
  • PHVS Switzerland
  • CIFR United States
  • Employees
  • PHVS N/A
  • CIFR N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • CIFR Investment Bankers/Brokers/Service
  • Sector
  • PHVS Health Care
  • CIFR Finance
  • Exchange
  • PHVS Nasdaq
  • CIFR Nasdaq
  • Market Cap
  • PHVS 909.5M
  • CIFR 882.1M
  • IPO Year
  • PHVS 2021
  • CIFR N/A
  • Fundamental
  • Price
  • PHVS $16.49
  • CIFR $3.25
  • Analyst Decision
  • PHVS Strong Buy
  • CIFR Strong Buy
  • Analyst Count
  • PHVS 5
  • CIFR 10
  • Target Price
  • PHVS $39.20
  • CIFR $8.03
  • AVG Volume (30 Days)
  • PHVS 59.6K
  • CIFR 20.8M
  • Earning Date
  • PHVS 05-13-2025
  • CIFR 05-06-2025
  • Dividend Yield
  • PHVS N/A
  • CIFR N/A
  • EPS Growth
  • PHVS N/A
  • CIFR N/A
  • EPS
  • PHVS N/A
  • CIFR N/A
  • Revenue
  • PHVS N/A
  • CIFR $152,092,000.00
  • Revenue This Year
  • PHVS N/A
  • CIFR $90.57
  • Revenue Next Year
  • PHVS N/A
  • CIFR $78.51
  • P/E Ratio
  • PHVS N/A
  • CIFR N/A
  • Revenue Growth
  • PHVS N/A
  • CIFR N/A
  • 52 Week Low
  • PHVS $11.51
  • CIFR $1.86
  • 52 Week High
  • PHVS $25.50
  • CIFR $7.99
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 51.83
  • CIFR 49.89
  • Support Level
  • PHVS $15.46
  • CIFR $3.34
  • Resistance Level
  • PHVS $16.99
  • CIFR $3.65
  • Average True Range (ATR)
  • PHVS 1.04
  • CIFR 0.27
  • MACD
  • PHVS -0.08
  • CIFR -0.05
  • Stochastic Oscillator
  • PHVS 71.48
  • CIFR 25.84

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About CIFR Cipher Mining Inc.

Cipher Mining Inc ia an emerging technology company that operates in the Bitcoin mining ecosystem in the United States. The company is developing a cryptocurrency mining business, specializing in Bitcoin. The company is expanding and strengthening the Bitcoin network's critical infrastructure in the United States.

Share on Social Networks: